[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers]. [PDF]
Silva MBFCD, Silva CFD, Silva MJSD.
europepmc +1 more source
Beyond Contrast Volume: Patient-Related Determinants and Methodological Considerations in Contrast-Induced NephropathyReply. [PDF]
Yilmaz ÖF, Şener YZ.
europepmc +1 more source
[Case report of human myiasis caused by Cochliomyia hominivorax in Mexico]. [PDF]
Hernández-Peláez DK +2 more
europepmc +1 more source
Drugs incorporated into the Brazilian Unified Health System: document analysis of methodological decisions in budget impact analyses between 2012 and 2024. [PDF]
Curado DDSP, Silva END.
europepmc +1 more source
Beta-blockers for Hypertension: To Be or Not to Be a First-line Drug? [PDF]
Barreto-Filho JAS +3 more
europepmc +1 more source
Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]
Caffaratti M +9 more
europepmc +1 more source
A segurança no circuito do medicamento: medicamentos de alta vigilância
Costa, C, Prata, P
openaire +1 more source

